serge verstovsek, md on myelofibrosis
Published 7 years ago • 69 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
7:29
serge verstovsek, md on myelofibrosis and thrombocytosis (full interview)
-
2:13
serge verstovsek, md on treatment of thrombocytosis patients intolerant or resistant to hydroxyurea
-
1:36
serge verstovsek, md on the phase 2 study involving ruxolitinib with azacytidine
-
2:19
myelofibrosis risk stratisfication
-
2:10
dr. verstovsek on accelerated phase myelofibrosis
-
1:19
dr. srdan verstovsek on jak2 inhibitors as a treatment for myelofibrosis
-
25:39
for myelofibrosis patients: latest on treatments from top doctor | dr. srdan verstovsek, md anderson
-
1:52
ruben mesa, md on myelofibrosis (full interview)
-
1:05
comfort-1: bone marrow morphology and myelofibrosis
-
24:31
managing myelofibrosis in 2021 - dr. srdan verstovsek
-
1:48
dr. verstovsek on examining cpi-0610 in myelofibrosis
-
1:23:15
drs.verstovsek & mesa discuss latest myelofibrosis updates from #soho2021: https://bit.ly/3hfp1kc
-
0:32
enrica marci, md discusses the need for creativity in orphan disease diagnosis
-
39:34
dr. verstovsek, md, phd-new approaches for mf
-
1:21
dr. verstovsek discusses immunotherapy in myelofibrosis
-
2:16
dr. verstovsek on limitations of the current treatment landscape of myelofibrosis
-
31:14
update on jak2 inhibitors by srdan verstovsek, md
-
4:11
impact of ruxolitinib approval on myelofibrosis real-world survival in the us
-
2:44
a 45-year old with polycythemia vera not responding to hydroxyurea